These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30952673)

  • 1. Two decades of excellent transplant survival for chronic granulomatous disease: a supraregional immunology transplant center report.
    Lum SH; Flood T; Hambleton S; McNaughton P; Watson H; Abinun M; Owens S; Cigrovski N; Cant A; Gennery AR; Slatter M
    Blood; 2019 Jun; 133(23):2546-2549. PubMed ID: 30952673
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
    Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
    J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens.
    Hönig M; Flegel WA; Schwarz K; Freihorst JF; Baumann U; Seltsam A; Debatin KM; Schulz AS; Friedrich W
    Bone Marrow Transplant; 2010 Jan; 45(1):209-11. PubMed ID: 19503108
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.
    Schuetz C; Hoenig M; Gatz S; Speth F; Benninghoff U; Schulz A; Debatin KM; Friedrich W
    Immunol Res; 2009; 44(1-3):35-41. PubMed ID: 18846320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive ability in children with chronic granulomatous disease: a comparison of those managed conservatively with those who have undergone hematopoietic stem cell transplant.
    Cole TS; McKendrick F; Cant AJ; Pearce MS; Cale CM; Goldblatt DR; Gennery AR; Titman P
    Neuropediatrics; 2013 Aug; 44(4):230-2. PubMed ID: 23397467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Transplant Outcomes in Children and Adolescents with Non-Malignant Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Zaucha-Prażmo A; Sadurska E; Pieczonka A; Goździk J; Dębski R; Drabko K; Zawitkowska J; Lejman M; Wachowiak J; Styczyński J; Kowalczyk JR
    Ann Transplant; 2019 Jun; 24():374-382. PubMed ID: 31235684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical stem cell transplantation in a boy with chronic granulomatous disease.
    Regueiro-García A; Fariña-Nogueira S; Porto-Arceo JÁ; Couselo-Sánchez JM
    Allergol Immunopathol (Madr); 2018; 46(4):385-388. PubMed ID: 29373243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
    Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
    Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplant for high-risk adult patients with chronic granulomatous disease: first case report from Iran.
    Ramzi M; Rezvani A; Haghighinejad H
    Exp Clin Transplant; 2014 Oct; 12(5):490-3. PubMed ID: 25299376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
    Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Lichtheimia ramosa Infection After Hematopoietic Stem Cell Transplantation in a Child With Chronic Granulomatous Disease.
    Winstead M; Ozolek J; Nowalk A; Williams J; Vander Lugt M; Lin P
    Pediatr Infect Dis J; 2017 Dec; 36(12):1222-1224. PubMed ID: 28333712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
    Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
    N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease.
    Bhatt ST; Schulz G; Hente M; Slater A; Murray L; Shenoy S; Bednarski JJ
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28030. PubMed ID: 31599480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.
    Morillo-Gutierrez B; Beier R; Rao K; Burroughs L; Schulz A; Ewins AM; Gibson B; Sedlacek P; Krol L; Strahm B; Zaidman I; Kalwak K; Talano JA; Woolfrey A; Fraser C; Meyts I; Müller I; Wachowiak J; Bernardo ME; Veys P; Sykora KW; Gennery AR; Slatter M
    Blood; 2016 Jul; 128(3):440-8. PubMed ID: 27216217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching.
    Reichenbach J; Van de Velde H; De Rycke M; Staessen C; Platteau P; Baetens P; Güngör T; Ozsahin H; Scherer F; Siler U; Seger RA; Liebaers I
    Pediatrics; 2008 Sep; 122(3):e778-82. PubMed ID: 18762514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.
    Åhlin A; Fugeläng J; de Boer M; Ringden O; Fasth A; Winiarski J
    Acta Paediatr; 2013 Nov; 102(11):1087-94. PubMed ID: 23937637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning.
    Osumi T; Tomizawa D; Kawai T; Sako M; Inoue E; Takimoto T; Tamura E; Uchiyama T; Imadome KI; Taniguchi M; Shirai R; Yoshida M; Ando R; Tsumura Y; Fuji H; Matsumoto K; Shioda Y; Kiyotani C; Terashima K; Onodera M; Matsumoto K; Kato M
    Bone Marrow Transplant; 2019 Jan; 54(1):168-172. PubMed ID: 29959437
    [No Abstract]   [Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation in adolescent patients with chronic granulomatous disease.
    Arnold DE; Seif AE; Jyonouchi S; Sullivan KE; Bunin NJ; Heimall JR
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1052-1054.e2. PubMed ID: 30391552
    [No Abstract]   [Full Text] [Related]  

  • 19. Lomentospora prolificans fungemia in hematopoietic stem cell transplant patients: First report in South America and literature review.
    Penteado FD; Litvinov N; Sztajnbok J; Thomaz DY; Dos Santos AM; Vasconcelos DM; Motta AL; Rossi F; Fernandes JF; Marques HHS; Benard G; de Almeida JN
    Transpl Infect Dis; 2018 Aug; 20(4):e12908. PubMed ID: 29679424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.